---
canonical_name: Butea superba
alternate_names: Red Kwao Krua, Kwao Krua Daeng, Red Gwow Kreur
canonical_topic: Butea superba to Improve Testosterone
short_topic_lc: butea_superba_testosterone
creation_date: 2026-0723-0009
creator_ai_fullname: Opus 4.8
---

# Butea superba to Improve Testosterone
<section id="top" markdown="1"></section>
Evidence Review created on 07/23/2026 using [AI4L](https://github.com/forever-healthy/AI4L) / Opus 4.8

**Also known as:** Red Kwao Krua, Kwao Krua Daeng, Red Gwow Kreur

  
## Motivation

<!-- This motivation section was written after the rest of the document was completed, so that it reflects the full scope of the topic. -->

*Butea superba* is a woody climbing plant native to Thailand and neighboring parts of Southeast Asia. Its underground tuber, known in Thai folk medicine as "Red Kwao Krua," has been used for generations as a tonic for male vigor, sexual performance, and vitality. In recent years it has been sold internationally as a capsule or extract marketed to raise testosterone, sharpen libido, and support erectile firmness, placing it in the crowded field of botanical "male enhancement" products.

The plant's reputation rests largely on traditional use rather than modern testing. Its tuber is rich in plant compounds called flavonoids and isoflavones, and laboratory work suggests it can relax the smooth muscle involved in erections. Human testing, however, is sparse, and one well-known study was undermined when the herbal product was found to be secretly mixed with a prescription erection drug.

This review examines what the available evidence does and does not show about *Butea superba* and testosterone: whether it meaningfully raises the hormone, how it may act in the body, the safety signals seen at higher doses, and the quality and purity concerns that surround the products sold today.

**[Benefits](#expected-benefits) - [Risks](#potential-risks--side-effects) - [Protocol](#therapeutic-protocol) - [Conclusion](#conclusion)**

  
## Recommended Reading

This section lists accessible, high-level sources that discuss *Butea superba* and its use for male sexual and hormonal health directly and in depth.

<!-- A real-time web search and PubMed search were performed for high-level overviews of Butea superba. The five priority experts (Rhonda Patrick, Peter Attia, Andrew Huberman, Chris Kresser, Life Extension) were each searched by name alongside the intervention; none were found to publish content addressing Butea superba specifically, so eligible narrative-review and primary-research articles that discuss the herb by name are listed instead. Marketing blogs (e.g., anabolicmen.com) were excluded because they blocked verification and are commercially conflicted. -->

* [Rise of herbal and traditional medicine in erectile dysfunction management](https://pubmed.ncbi.nlm.nih.gov/21948222/) - Ho & Tan, 2011

  A narrative review that places *Butea superba* among the handful of herbs (alongside *Panax ginseng* and yohimbine) with any published human data for erectile dysfunction (ED, the inability to reach or keep an erection), and candidly notes that those human trials are few and not robust.

* [The use of Butea superba (Roxb.) compared to sildenafil for treating erectile dysfunction](https://pubmed.ncbi.nlm.nih.gov/19624593/) - Cortés-González et al., 2010

  A cautionary human comparison in which *Butea superba* initially appeared to rival sildenafil, but the benefit vanished in the blinded phase after the supplier confirmed the first batch had been spiked with a phosphodiesterase type 5 (PDE5) inhibitor — a vivid illustration of the adulteration risk in this product category.

* [Butea superba Roxb. enhances penile erection in rats](https://pubmed.ncbi.nlm.nih.gov/16619349/) - Tocharus et al., 2006

  A mechanistic animal study showing the extract raises pressure inside the erectile tissue with a bell-shaped dose response, and relaxes smooth muscle through the cyclic-AMP/cyclic-GMP messenger pathways that also underlie standard PDE5 inhibitors.

* [Androgen disruption and toxicity tests of Butea superba Roxb., a traditional herb used for treatment of erectile dysfunction, in male rats](https://pubmed.ncbi.nlm.nih.gov/18554827/) - Cherdshewasart et al., 2008

  A 90-day toxicity study that is essential reading because it found the opposite of the marketing claim: high doses produced a dose-dependent fall in blood testosterone along with liver-enzyme and blood-count changes.

* [Effects of Butea superba on reproductive systems of rats](https://pubmed.ncbi.nlm.nih.gov/16889907/) - Manosroi et al., 2006

  An eight-week feeding study reporting modest increases in testis weight and sperm count at the highest dose with no organ toxicity, offering a measured counterpoint on the herb's reproductive effects and margin of safety in animals.

<!-- Note to reader: No content addressing Butea superba was located from any of the five priority experts or publications despite dedicated searches, likely because this is a niche traditional Thai herb rather than a mainstream supplement; the list above therefore draws on the peer-reviewed literature that discusses the herb by name. -->

  
## Grokipedia

<!-- grokipedia.com was searched directly using the browser tool on 07/23/2026. A dedicated article titled "Butea superba" exists at https://grokipedia.com/page/Butea_superba and loads successfully (HTTP 200). -->

* [Butea superba](https://grokipedia.com/page/Butea_superba)

  Grokipedia's article gives a broad reference overview of the plant — its botany, traditional use as a male rejuvenative tonic, and the pharmacological research on its androgenic, antioxidant, and erectile effects — complementing this review's narrower focus on the testosterone evidence.

  
## Examine

<!-- examine.com was searched directly using the browser tool on 07/23/2026 for "Butea superba." Examine maintains a dedicated supplement page for the herb at the URL below. -->

* [Butea superba](https://examine.com/supplements/butea-superba/)

  Examine's independent, evidence-graded supplement page summarizes the human and animal research on *Butea superba* for sexual function and testosterone, and is a useful neutral reference that reaches the same conclusion as this review: the human evidence is weak and largely limited to erectile function.

  
## ConsumerLab

<!-- consumerlab.com was searched directly using the browser tool on 07/23/2026 for "Butea superba." No dedicated product review or article for Butea superba was found; the only related results were a general "Sexual Enhancer Supplements Review" and FDA recall notices for adulterated sexual-enhancement products, neither of which is specific to this herb. -->

No dedicated *Butea superba* review exists on ConsumerLab; the herb is not covered as a standalone product, appearing only within a general sexual-enhancement supplement review and unrelated recall notices.

  
## Systematic Reviews

No systematic reviews or meta-analyses for *Butea superba* were found on PubMed as of July 23, 2026.

  
## Mechanism of Action

*Butea superba* is a botanical extract rather than a single defined compound, so its actions come from a mixture of plant chemicals concentrated in the tuber — chiefly isoflavones such as genistein, daidzein, and biochanin A, along with other flavonoids and sterol-like molecules. Because it is a plant extract, it has no single half-life, selectivity, or metabolic pathway; potency varies widely with species identity, harvest season, and preparation.

The best-supported mechanism concerns erections rather than testosterone. Laboratory work shows the extract relaxes the smooth muscle of erectile tissue and raises internal pressure by acting on the cyclic-AMP (cAMP) and cyclic-GMP (cGMP) messenger systems — the same second messengers that standard erectile-dysfunction medications preserve by blocking phosphodiesterase type 5 (PDE5, the enzyme that breaks cGMP down). This gives a plausible, sildenafil-like route to firmer erections that is largely independent of any change in hormone levels.

The testosterone story is far weaker and internally conflicting. Marketing frames the herb as "androgenic" (testosterone-like), and it does show weak androgen-like and anti-estrogen effects on reproductive organs in rodents. Yet direct hormone measurements are inconsistent: in intact male rats, serum testosterone, luteinizing hormone (LH, the pituitary signal that drives the testes to make testosterone), and follicle-stimulating hormone (FSH, a related pituitary hormone that governs sperm production) were unchanged at typical doses, and high doses actually lowered testosterone. The isoflavones it contains also bind estrogen receptors, so a phytoestrogen (plant-estrogen) effect competes with the claimed androgen effect. There is no established pathway by which *Butea superba* reliably raises testosterone in humans.

  
## Historical Context & Evolution

*Butea superba* has been used in Thai traditional medicine for centuries as one of the "Kwao Krua" rejuvenating tubers, prized as a male aphrodisiac and general tonic ("Red Kwao Krua" distinguishes it from the estrogenic "White Kwao Krua," *Pueraria candollei*). Its original use was folkloric — a remedy for waning male vigor, low libido, and the effects of aging — long before any laboratory characterization existed.

Interest for health optimization grew in the early 2000s when Thai research groups, principally at Chulalongkorn University, began testing the tuber for erectile and hormonal effects; a 2003 randomized trial reporting improved erectile scores catalyzed its export as a testosterone and "male enhancement" supplement.

The findings that followed are best read directly rather than as a settled verdict. Animal work documented genuine erection-enhancing and mild reproductive effects, but also showed testosterone falling at high doses and weak estrogen-receptor activity, complicating the simple "testosterone booster" narrative. A 2010 human comparison against sildenafil collapsed when the herbal product proved to be adulterated with a hidden PDE5 inhibitor, which reframed part of the herb's apparent potency as contamination rather than plant action. The current picture is therefore unresolved: a plausible erectile benefit, an unproven testosterone benefit, and unresolved questions about purity — with no large, standardized human trials yet available to close the gap.

  
## Expected Benefits

<!-- A dedicated search across PubMed, Examine, and general web sources was performed for the complete benefit profile of Butea superba before writing this section. -->

The benefits below are framed for health- and longevity-oriented adults considering *Butea superba* specifically to raise testosterone; the evidence for that specific goal is weak, and the strongest signal is for erectile function rather than the hormone itself.


### Low 🟩

#### Erectile Function Support ⚠️ Conflicted

This is the only benefit with any direct human evidence. A single three-month randomized, double-blind trial in Thai men with erectile dysfunction reported improvement on four of five items of the International Index of Erectile Function (IIEF-5, a validated erection questionnaire), with about 82% of participants judged improved. Animal studies support a mechanism, showing increased erectile-tissue pressure via the cAMP/cGMP pathways. The evidence is graded Low and flagged conflicted because the trial was small and unreplicated, and a separate human comparison against sildenafil found the herb's apparent effect disappeared once an adulterating PDE5 inhibitor was removed — leaving genuine unadulterated efficacy uncertain.

**Magnitude:** Roughly 82% of men rated as improved on IIEF-5 in one small trial; no reliable, adulteration-free effect size exists.


### Speculative 🟨

#### Testosterone Elevation

This is the marketed benefit and the goal of this review, yet it is the least supported. No human study demonstrates that *Butea superba* raises testosterone; the widely repeated claim rests on traditional "androgenic" framing and weak, indirect animal signals (mild androgen-like effects on reproductive organs). Direct hormone measurements in intact male rats showed no change in testosterone at usual doses, and high doses lowered it — the reverse of the marketing claim. Because the basis is mechanistic and folkloric rather than clinical, this benefit is classified Speculative.

#### Libido and Sexual Desire

Traditional use centers as much on desire as on erectile mechanics, and improved erectile confidence could indirectly enhance libido. However, no controlled human study isolates a libido effect, and any hormonal driver is unproven. The basis here is anecdotal and traditional rather than experimental.

#### Antioxidant and Vascular Support

Laboratory studies report that the extract scavenges free radicals and can slow oxidation of isolated human LDL (low-density lipoprotein, the "bad" cholesterol particle that contributes to artery plaque), an effect attributed to its isoflavones. This is a test-tube finding with no human outcome data, so any cardiovascular or longevity relevance is speculative.

  
## Benefit-Modifying Factors

* **Genetic polymorphisms:** No pharmacogenetic data exist for *Butea superba*, so no variant is known to enhance or predict its benefit; because its isoflavones are handled by liver conjugation enzymes and act partly through estrogen receptors, individual differences in these pathways could in theory alter responsiveness, but this is entirely unquantified.

* **Baseline testosterone status:** Any hormonal benefit, if real, would most plausibly appear in men who start with low or borderline testosterone rather than those already in the optimal range; animal data suggest the herb needs endogenous testosterone present to act on accessory sex organs, implying little to offer men with already-normal levels.

* **Baseline erectile and vascular health:** The erectile signal is mechanistic (smooth-muscle relaxation), so men whose erectile difficulty is vascular in origin may notice more than men whose issue is purely hormonal or psychological.

* **Sex-based differences:** Evidence is almost entirely in males, consistent with its traditional male-tonic use. In female rats the herb showed androgen-like effects on reproductive tissue, suggesting benefits (and risks) differ by sex; there is no basis to expect a testosterone benefit in women, in whom androgen excess would be undesirable.

* **Age:** Interest concentrates in middle-aged and older men experiencing age-related decline in androgens and erectile firmness; older users at the upper end of the target range are also those most exposed to the herb's high-dose safety signals and drug interactions, narrowing any favorable balance.

* **Pre-existing conditions:** Men with diabetes-related erectile dysfunction showed an erectile response in an animal model, hinting the vascular mechanism may still operate in that group, though this has not been confirmed in humans.

  
## Potential Risks & Side Effects

<!-- A dedicated search of the toxicology literature, case reports, drug-reference sources, and FDA recall notices was performed for the complete safety profile of Butea superba before writing this section. -->

Risks are framed for proactive adults who may self-experiment with imported, loosely regulated products. The single most important hazard is not the plant itself but what commercial products are sometimes contaminated with.


### Medium 🟥 🟥

#### Product Adulteration with Hidden Prescription Drugs

The best-documented danger is that commercial "*Butea superba*" products are adulterated with undeclared PDE5 inhibitors (the drug class that includes sildenafil and tadalafil). In a published human study the herb's apparent potency was traced to exactly such spiking, confirmed by the supplier. Regulators have repeatedly recalled sexual-enhancement supplements for undeclared drugs. The consequence is serious: a consumer who also takes nitrates for heart disease, or another PDE5 inhibitor, can suffer dangerous blood-pressure drops without knowing they took a pharmaceutical at all. The evidence is graded Medium because adulteration is documented in this specific product and widespread across the category, though not present in every batch.

**Magnitude:** Documented in at least one clinical study of a marketed batch; sexual-enhancement supplements are among the most frequently recalled categories for undeclared drugs.


### Low 🟥

#### Testosterone Suppression at High Doses ⚠️ Conflicted

Paradoxically for a product sold to raise testosterone, a 90-day rat study found a dose-dependent decrease in blood testosterone at high doses. Whether this occurs in humans is unknown, and lower doses showed no hormonal change, so the finding is graded Low and conflicting. It nonetheless undercuts the core marketing claim and warns against the "more is better" dosing common among self-experimenters.

**Magnitude:** Dose-dependent testosterone reduction in rats at roughly 150–200 mg/kg/day; human equivalent and threshold not established.

#### Hepatic and Blood-Chemistry Changes

The same subchronic rat study reported raised liver enzymes — alkaline phosphatase (ALP) and aspartate aminotransferase (AST), markers that rise when liver or related tissue is stressed — plus increased spleen weight and shifts in white-blood-cell counts at high doses. These signal potential liver and blood effects with prolonged high intake. Graded Low because they derive from animal data at supraphysiologic doses, with no confirmed human hepatotoxicity.

**Magnitude:** Elevated ALP and AST and altered blood counts in rats at 150–200 mg/kg/day; not quantified in humans.

#### Cardiovascular and Blood-Pressure Effects

Through its erectile, vasodilatory mechanism — and especially when a product is adulterated with a PDE5 inhibitor — the herb can lower blood pressure and interact dangerously with nitrates and other vasodilators. The animal dose-response for erectile pressure was bell-shaped, hinting effects are not simply dose-proportional. Graded Low for the plant itself but clinically important in the adulteration scenario above.

**Magnitude:** Not quantified in available studies.


### Speculative 🟨

#### Genotoxicity Signal

A toxicology study using a micronucleus test found increased chromosomal damage markers in rats at a very high dose (1,000 mg/kg/day), though a companion reproductive-toxicity test was negative. This is an isolated animal signal at an extreme dose, with no human data, and is included for completeness rather than as an established risk.

#### Hormonal Disruption from Phytoestrogen Activity

Because the tuber's isoflavones bind estrogen receptors and show both estrogenic and anti-estrogenic activity depending on conditions, chronic use could theoretically perturb the estrogen–androgen balance in unpredictable ways. No human endocrine outcomes have been measured, so this remains mechanistic.

#### Hyperandrogenemia (Case Report)

A single published case linked ingestion of *Butea superba* to abnormally high blood androgen levels in one person. As an uncontrolled single report, it cannot establish causation but suggests idiosyncratic hormonal responses are possible.

  
## Risk-Modifying Factors

* **Genetic polymorphisms:** No pharmacogenetic data exist for *Butea superba*. Because its isoflavones are handled by liver conjugation enzymes and it may affect the same erectile pathway as PDE5 inhibitors, individuals with variants affecting drug metabolism or those genetically prone to liver-enzyme elevation could in theory respond differently, but this is unquantified.

* **Baseline liver and blood biomarkers:** Users starting with elevated liver enzymes or abnormal blood counts have less margin against the hepatic and hematologic changes seen in animals, making baseline testing prudent.

* **Sex-based differences:** Women and men differ markedly: androgen-like effects that are the goal in men would be an adverse hyperandrogenic effect in women, and phytoestrogen activity adds further sex-specific uncertainty.

* **Pre-existing conditions:** Cardiovascular disease (especially nitrate therapy), liver disease, and hormone-sensitive conditions raise the stakes of both the plant's effects and the well-documented adulteration risk.

* **Age:** Older men, the main user group, more often take nitrates or other PDE5 inhibitors and have reduced hepatic reserve, amplifying interaction and toxicity concerns.

  
## Key Interactions & Contraindications

* **PDE5 inhibitors (sildenafil, tadalafil, vardenafil):** Additive effect on the erectile/vasodilatory pathway, compounded by the real possibility that a product is already spiked with one. Severity: caution to avoid; consequence: excessive vasodilation and hypotension. Mitigation: do not combine; treat any product as potentially containing a hidden PDE5 inhibitor.

* **Nitrates and nitric-oxide donors (nitroglycerin, isosorbide):** Absolute contraindication if the product contains, or is contaminated with, a PDE5 inhibitor. Consequence: severe, potentially life-threatening drop in blood pressure. Mitigation: complete avoidance in anyone using nitrates.

* **Antihypertensive drugs (alpha-blockers such as doxazosin, other blood-pressure medicines):** Possible additive blood-pressure lowering. Severity: monitor; consequence: dizziness, fainting. Mitigation: monitor blood pressure; separate timing.

* **Anticoagulant and antiplatelet drugs (warfarin, aspirin, clopidogrel):** Theoretical additive effect given flavonoid content; unquantified. Severity: caution; consequence: possible increased bleeding tendency. Mitigation: monitor if combined.

* **Hormone-active supplements and therapies (testosterone, DHEA [dehydroepiandrosterone, an adrenal precursor hormone], estrogen-modulating herbs):** Overlapping and unpredictable endocrine effects given the herb's mixed androgen/estrogen activity. Severity: caution; consequence: unpredictable hormonal shifts. Mitigation: avoid stacking multiple hormone-active agents.

* **Populations who should avoid it:** Men taking nitrates or other PDE5 inhibitors; anyone with significant liver disease; those with hormone-sensitive cancers (e.g., prostate cancer); and women, particularly during pregnancy or breastfeeding, given androgenic and phytoestrogen activity and the absence of safety data.

  
## Risk Mitigation Strategies

* **Treat every product as possibly adulterated:** The central documented risk is hidden PDE5 inhibitors; choosing brands with third-party testing that specifically screens for undeclared pharmaceuticals directly counters the adulteration and hypotension hazard.

* **Avoid the "more is better" trap:** Because high doses in animals lowered testosterone and stressed the liver, keeping to the low end of label dosing (commonly 400 mg or less of root powder) mitigates the testosterone-suppression and hepatic-enzyme risks.

* **Screen for nitrate and PDE5-inhibitor use first:** Confirming a user is not taking nitrates or another PDE5 inhibitor before starting prevents the most dangerous interaction — severe hypotension.

* **Baseline and periodic liver and hormone testing:** Checking liver enzymes (ALP, AST, and ALT [alanine aminotransferase]), testosterone, and related hormones before and during use catches the hepatic and hormonal changes flagged in animal studies early.

* **Time-limited trials rather than open-ended use:** Limiting any trial to a defined window (for example, 8–12 weeks) with reassessment reduces cumulative exposure given the absence of long-term human safety data.

  
## Therapeutic Protocol

There is no evidence-based, standardized protocol for *Butea superba*, and no leading clinical practitioner endorses it as a testosterone therapy; the "protocol" below reflects how commercial products and traditional use are structured, not a validated regimen.

* **Typical dose:** Commercial capsules commonly supply 400–1,000 mg of dried tuber (root) powder daily, or smaller amounts of concentrated extract. The Thai traditional recommended dose is low; the 2003 human trial used a crude tuber preparation.

* **Standard approach vs. alternatives:** The main alternative to an unproven herb for genuinely low testosterone is medically supervised testosterone therapy, and for erectile dysfunction, approved PDE5 inhibitors — both with far stronger evidence. These are presented as the better-characterized options, not as a default this herb should be measured against.

* **Best time of day:** No chronobiological data exist; because the plausible effect is on erectile tissue, users typically dose in the morning or before intended activity, but this is convention, not evidence.

* **Half-life:** As a multi-component plant extract, it has no defined half-life; isoflavones such as genistein and daidzein have circulating half-lives of several hours, suggesting effects would not be long-sustained.

* **Single vs. split dosing:** No data guide this; label directions vary, and given the bell-shaped dose-response seen for erectile effects in animals, escalating doses is not supported.

* **Genetic considerations:** No pharmacogenetic guidance (e.g., for metabolism-related variants) exists to individualize dosing.

* **Sex-based differences:** Protocols and traditional use are male-specific; there is no dosing basis for women, in whom androgenic effects would be adverse.

* **Age considerations:** Older men should weigh reduced hepatic reserve and greater likelihood of interacting medications when considering any dose.

* **Baseline biomarkers:** Any trial is most rational in men with documented low testosterone and normal liver tests, reassessed against objective markers rather than perceived effect.

* **Pre-existing conditions:** Liver disease, cardiovascular disease on nitrates, and hormone-sensitive cancers argue against use regardless of dose.

  
## Discontinuation & Cycling

* **Lifelong vs. short-term:** Nothing supports indefinite use; given the lack of long-term safety data and unproven benefit, use is best conceived as a short, defined trial rather than a maintenance therapy.

* **Withdrawal effects:** No withdrawal syndrome has been described; because it is not known to suppress the body's own hormone production at usual doses, abrupt cessation is not expected to cause rebound.

* **Tapering:** No tapering protocol is established or appears necessary at typical doses.

* **Cycling:** No evidence shows cycling maintains efficacy; cycling is sometimes advocated in supplement marketing to limit tolerance or hormonal disruption, but there is no data to support a specific on/off schedule for this herb.

  
## Sourcing and Quality

* **Adulteration screening is paramount:** The dominant quality issue is contamination with undeclared PDE5 inhibitors; look for brands that publish third-party certificates of analysis specifically testing for hidden pharmaceuticals, not just for label potency.

* **Species authentication:** DNA-barcoding studies show frequent misidentification and substitution among the three "Kwao Krua" plants (*Butea superba*, *Pueraria candollei*, *Mucuna* species); reputable suppliers should verify botanical identity, because the estrogenic White Kwao Krua is a common and hormonally opposite substitute.

* **Standardization:** Active isoflavone content varies with harvest season and plant part, so products standardized to a stated flavonoid or isoflavone content are preferable to unquantified "root powder."

* **Reputable formats:** Established supplement brands that provide contaminant testing and clear species identification are preferable to unbranded imported products marketed purely for "male enhancement," which carry the highest adulteration risk.

* **Regulatory status:** In the United States it is sold as a dietary supplement without pre-market efficacy or purity review, so quality assurance falls entirely on the manufacturer and buyer.

  
## Practical Considerations

* **Time to effect:** The one human erectile trial ran three months; any erectile effect would plausibly emerge over weeks, and there is no evidence of a measurable testosterone change on any timescale.

* **Common pitfalls:** Assuming the product is pure (ignoring adulteration), escalating the dose in pursuit of a testosterone effect (which animal data suggest can backfire), and mistaking a hidden PDE5 inhibitor's effect for the herb's action are the most common errors.

* **Regulatory status:** Sold as an unregulated dietary supplement in most Western markets and used off any formal indication; not an approved medicine for testosterone or erectile dysfunction.

* **Cost and accessibility:** Generally inexpensive and widely available online, which paradoxically increases exposure to low-quality, potentially adulterated imports.

  
## Interaction with Foundational Habits

* **Sleep:** Interaction direction: none established. No evidence links *Butea superba* to sleep quality in either direction; sleep remains a far more reliable lever on testosterone than the herb itself, since deep sleep drives natural testosterone production.

* **Nutrition:** Interaction direction: indirect. As an isoflavone-rich botanical it overlaps with dietary phytoestrogens (e.g., soy), so users with high soy intake add to their total phytoestrogen load; no specific food pairing is shown to enhance or block its effects, and adequate zinc and vitamin D status support testosterone independently.

* **Exercise:** Interaction direction: none established, potentially indirect. There is no evidence it aids muscle or training adaptation; resistance training and maintaining a healthy body-fat level have well-established testosterone benefits that any herbal effect would be small against.

* **Stress management:** Interaction direction: indirect. Chronic stress and elevated cortisol suppress testosterone and worsen erectile function; while the herb has shown antidepressant-like effects in rodent stress models, this is not established in humans, and stress reduction is a more dependable route to hormonal and sexual health.

  
## Monitoring Protocol & Defining Success

Baseline testing establishes whether a testosterone problem actually exists before trialing an unproven herb and provides a safety reference for the liver and blood-count signals seen in animals. Baseline labs should be drawn before starting; on-treatment labs are reasonable at roughly 6–8 weeks and again at 12 weeks if use continues, after which continued use is hard to justify without objective benefit.

* Confirm a genuine baseline: a morning total and free testosterone plus LH and FSH before any trial, so that "success" is defined by objective hormone change, not perception.

Ongoing monitoring cadence: repeat the key hormone and liver panels at about 6–8 weeks and 12 weeks, then discontinue if no objective benefit is seen.

| Biomarker | Optimal Functional Range | Why Measure It? | Context/Notes |
|-----------|--------------------------|-----------------|---------------|
| Total testosterone | ~500–900 ng/dL | Defines whether a deficit exists and whether the herb changes it | Draw fasting, 7–10 a.m.; conventional lab range is broader (~264–916 ng/dL) |
| Free testosterone | ~15–25 pg/mL (upper half) | The bioavailable fraction most tied to symptoms | Best paired with sex hormone-binding globulin (SHBG); assay methods vary |
| Luteinizing hormone (LH) | ~2–8 IU/L | Pituitary signal to make testosterone; helps locate cause of low levels | Interpreted alongside FSH and testosterone |
| Follicle-stimulating hormone (FSH) | ~1.5–8 IU/L | Distinguishes testicular vs. pituitary causes | Paired with LH |
| Sex hormone-binding globulin (SHBG) | ~20–40 nmol/L | Determines how much testosterone is free vs. bound | Needed to calculate free testosterone; raised by aging |
| Estradiol | ~20–30 pg/mL | Herb's isoflavones act on estrogen pathways; watch for imbalance | Use a sensitive assay for men |
| ALT / AST | ALT <25 U/L; AST <25 U/L | Detects the liver stress flagged in animal studies | Conventional upper limits (~40 U/L) are higher than functional optima |
| Alkaline phosphatase (ALP) | ~40–100 U/L | Rose at high doses in animals; liver/bone marker | Fasting preferred |
| Prostate-specific antigen (PSA) | <1.0–1.5 ng/mL | Prudent given androgenic marketing and prostate sensitivity | Avoid ejaculation/cycling 48 h before draw |
| Hematocrit (within CBC) | ~40–48% | High-dose animal data altered blood counts; androgens can thicken blood | Part of complete blood count (CBC) |

* **Qualitative markers of success:**

  - Erection quality and frequency (the outcome with the only human data)
  - Libido and sexual satisfaction
  - Energy and general vitality
  - Any adverse signs: unusual fatigue, abdominal discomfort (possible liver strain), dizziness or lightheadedness (possible blood-pressure effect)

  
## Emerging Research

Content below is framed for proactive adults tracking whether the evidence base for *Butea superba* is likely to strengthen or weaken.

* **No registered clinical trials:** A search of ClinicalTrials.gov on 07/23/2026 returned no registered interventional or observational trials of *Butea superba* for testosterone, erectile function, or any indication, so no ongoing trial NCT identifiers are available to cite. This absence is itself informative: the human evidence base is not currently expanding through registered trials.

* **Antioxidant and cardiovascular direction (could strengthen a secondary case):** A 2024 laboratory study, [Free radical scavenging and anti-isolated human LDL oxidation activities of Butea superba Roxb. extract](https://pubmed.ncbi.nlm.nih.gov/38310207/) (Sirichaiwetchakoon & Eumkeb, 2024), identified genistein, daidzein, and biochanin A as drivers of antioxidant and LDL-protective activity, pointing toward possible vascular applications that would need human testing.

* **Hormonal-mechanism direction (could weaken the testosterone claim):** The androgen-and-toxicity findings of [Cherdshewasart et al., 2008](https://pubmed.ncbi.nlm.nih.gov/18554827/) and the luteinizing-hormone data of [Malaivijitnond et al., 2010](https://pubmed.ncbi.nlm.nih.gov/20721473/) show testosterone falling at high doses and no consistent hormone rise at usual doses; replication in humans would likely further undercut the "testosterone booster" positioning.

* **Purity and standardization direction:** Ongoing DNA-barcoding and phytochemical work on distinguishing the Kwao Krua species and characterizing tuber constituents is the most active research front, and is a prerequisite for any credible future efficacy trial.

* **Key open question:** No adequately powered, adulteration-controlled human trial has tested whether a standardized *Butea superba* extract changes testosterone at all — the single study that would most change current understanding of this specific goal.

  
## Conclusion

*Butea superba*, the Thai "Red Kwao Krua," is a traditional male tonic now sold as a testosterone booster, but the evidence for that specific claim is weak. The strongest human signal is for erectile function, from one small, unreplicated study, and even that is clouded by a documented case in which the herbal product was secretly mixed with a prescription erection drug. For testosterone itself there is essentially no human proof of benefit; laboratory animal work is inconsistent and, at high doses, testosterone actually fell rather than rose.

Safety concerns are led not by the plant but by the products: contamination with hidden pharmaceuticals is the clearest hazard, and can be dangerous for anyone taking heart medicines called nitrates. Animal studies at high doses also raised liver and blood-count flags, and the plant's mixed hormone-like activity adds uncertainty.

The overall evidence base is small, largely from a few research groups and animal models, and shaped by a supplement market with a direct financial stake in optimistic claims. A person seeking higher testosterone will find far better-characterized options in medically supervised care. What the current evidence supports is caution, attention to product purity, and realistic expectations rather than confidence that this herb meaningfully raises testosterone.

**[Top](#top) - [Benefits](#expected-benefits) - [Risks](#potential-risks--side-effects) - [Protocol](#therapeutic-protocol)**